GRI Bio, Inc. Files 8-K
Ticker: GRI · Form: 8-K · Filed: Jun 26, 2025 · CIK: 1824293
Sentiment: neutral
Topics: 8-K, disclosure, financials
TL;DR
GRI Bio filed an 8-K on 6/26/25 for Reg FD disclosure & financials.
AI Summary
GRI Bio, Inc. filed an 8-K on June 26, 2025, reporting on a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Vallon Pharmaceuticals, Inc. and GRI BIO, Inc., is incorporated in Delaware and headquartered in La Jolla, California.
Why It Matters
This filing provides an update on GRI Bio, Inc.'s regulatory disclosures and financial statements, which are crucial for investors to assess the company's current standing and future prospects.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K, not indicating any specific new risks or material events.
Key Numbers
- 001-40034 — SEC File Number (Identifies the company's filing with the SEC)
- 82-4369909 — IRS Employer Identification No. (Company's tax identification number)
Key Players & Entities
- GRI Bio, Inc. (company) — Registrant
- June 26, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- La Jolla, CA (location) — Principal executive offices
- Vallon Pharmaceuticals, Inc. (company) — Former company name
- GRI BIO, Inc. (company) — Former company name
FAQ
What specific information is being disclosed under Regulation FD?
The filing indicates a Regulation FD Disclosure, but the specific details of this disclosure are not provided in the provided text.
What types of financial statements and exhibits are included in this filing?
The filing states 'Financial Statements and Exhibits' are included, but the specific nature or content of these documents is not detailed in the provided text.
When was GRI Bio, Inc. previously known as Vallon Pharmaceuticals, Inc.?
The date of the name change from Vallon Pharmaceuticals, Inc. to GRI BIO, Inc. was April 24, 2023.
What is GRI Bio, Inc.'s fiscal year end?
GRI Bio, Inc.'s fiscal year ends on December 31.
What is the primary business of GRI Bio, Inc. according to its SIC code?
GRI Bio, Inc.'s Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 26, 2025 regarding GRI Bio, Inc. (GRI).